Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00134-024-07699-8 | DOI Listing |
J Clin Endocrinol Metab
December 2024
Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
Context: Height outcome in patients with classic congenital adrenal hyperplasia (CAH) is suboptimal due to glucocorticoid and androgen excess.
Methods: In an open, randomized, controlled trial, children with classic CAH were randomized to receive a combination regimen of antiandrogen, aromatase inhibitor, reduced hydrocortisone, and fludrocortisone prior to puberty or standard therapy (hydrocortisone, fludrocortisone). Females continued on antiandrogen during puberty.
Endocrinol Diabetes Metab Case Rep
October 2024
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
Intensive Care Med
December 2024
Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK.
An Pediatr (Engl Ed)
November 2024
Hospital Universitario Miguel Servet, Zaragoza, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!